These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Delaware
|
86-0629024
|
|
|
(State or Other Jurisdiction of
Incorporation or Organization)
|
(IRS Employer
Identification No.)
|
|
Title of Each Class
|
Name of Each Exchange on Which Registered
|
|
Common Stock, $0.001 Par Value Per Share
|
Nasdaq Global Market
|
|
Preferred Share Purchase Rights
|
None
|
|
Large accelerated filer
|
ý
|
Accelerated filer
|
¨
|
Non-accelerated filer
|
¨
|
Smaller reporting company
|
¨
|
|
(Do not check if smaller reporting company)
|
|||||||
|
Documents Incorporated by Reference
|
||
|
Document
|
Part of Form 10-K
|
|
|
Proxy Statement for the 2010 Annual Meeting of Stockholders
|
III
|
|
|
|
·
|
our annual report on Form 10-K
|
|
|
·
|
our quarterly reports on Form 10-Q
|
|
|
·
|
our current reports on Form 8-K
|
|
|
·
|
our proxy statement
|
|
|
·
|
any amendments to the above-listed reports filed or furnished pursuant to Sections 13(a) or 15(d) of the Securities Exchange Act of 1934
|
|
|
·
|
differentiate their products
|
|
|
·
|
replace less efficient electromechanical control devices
|
|
|
·
|
reduce the number of components in their system
|
|
|
·
|
add product functionality
|
|
|
·
|
reduce the system level energy consumption
|
|
|
·
|
decrease time to market for their products
|
|
|
·
|
significantly reduce product cost
|
|
|
·
|
automotive comfort, safety and entertainment applications
|
|
|
·
|
remote control devices
|
|
|
·
|
handheld tools
|
|
|
·
|
home appliances
|
|
|
·
|
portable computers
|
|
|
·
|
robotics
|
|
|
·
|
accessories
|
|
|
·
|
cordless and cellular telephones
|
|
|
·
|
motor controls
|
|
|
·
|
security systems
|
|
|
·
|
educational and entertainment devices
|
|
|
·
|
consumer electronics
|
|
|
·
|
power supplies
|
|
|
·
|
touch screens
|
|
|
·
|
medical products
|
|
|
·
|
microcontrollers
|
|
|
·
|
development tools
|
|
|
·
|
analog and interface products
|
|
|
·
|
memory products
|
|
|
·
|
Tempe, Arizona (Fab 2)
|
|
|
·
|
Chandler, Arizona (probe operations)
|
|
|
·
|
Gresham, Oregon (Fab 4)
|
|
|
·
|
Bangkok, Thailand (assembly, probe and test)
|
|
Year Ended March 31,
|
||||||||||||||||||||||||
|
2010
|
2009
|
2008
|
||||||||||||||||||||||
|
Americas
|
$ | 231,398 | 24.4 | % | $ | 228,922 | 25.3 | % | $ | 273,363 | 26.4 | % | ||||||||||||
|
Europe
|
237,354 | 25.1 | 257,407 | 28.5 | 308,171 | 29.8 | ||||||||||||||||||
|
Asia
|
478,977 | 50.5 | 416,968 | 46.2 | 454,203 | 43.8 | ||||||||||||||||||
|
Total Sales
|
$ | 947,729 | 100.0 | % | $ | 903,297 | 100.0 | % | $ | 1,035,737 | 100.0 | % | ||||||||||||
|
|
·
|
speed
|
|
|
·
|
functionality
|
|
|
·
|
density
|
|
|
·
|
power consumption
|
|
|
·
|
reliability
|
|
|
·
|
packaging alternatives
|
|
|
·
|
ease of use
|
|
|
·
|
functionality of application development systems
|
|
|
·
|
dependable delivery, quality and availability
|
|
|
·
|
technical service and support
|
|
|
·
|
price
|
|
Name
|
Age
|
Position
|
|
Steve Sanghi
|
54
|
Chairman of the Board, President and Chief Executive Officer
|
|
Ganesh Moorthy
|
50
|
Executive Vice President & Chief Operating Officer
|
|
J. Eric Bjornholt
|
39
|
Vice President, Chief Financial Officer
|
|
Stephen V. Drehobl
|
48
|
Vice President, Security, Microcontroller and Technology Division
|
|
David S. Lambert
|
58
|
Vice President, Fab Operations
|
|
Mitchell R. Little
|
58
|
Vice President, Worldwide Sales and Applications
|
|
Richard J. Simoncic
|
46
|
Vice President, Analog and Interface Products Division
|
|
Item 1A
.
|
RISK FACTORS
|
|
|
·
|
changes in demand or market acceptance of our products and products of our customers;
|
|
|
·
|
levels of inventories at our customers;
|
|
|
·
|
the mix of inventory we hold and our ability to satisfy orders from our inventory;
|
|
|
·
|
risk of excess and obsolete inventories;
|
|
|
·
|
changes in utilization of our manufacturing capacity and fluctuations in manufacturing yields;
|
|
|
·
|
our ability to secure sufficient wafer foundry, assembly and testing capacity;
|
|
|
·
|
availability of raw materials and equipment;
|
|
|
·
|
competitive developments including pricing pressures;
|
|
|
·
|
unauthorized copying of our products resulting in pricing pressure and loss of sales;
|
|
|
·
|
the level of orders that are received and can be shipped in a quarter;
|
|
|
·
|
the level of sell-through of our products through distribution;
|
|
|
·
|
fluctuations in the mix of products;
|
|
|
·
|
changes or fluctuations in customer order patterns and seasonality;
|
|
|
·
|
constrained availability from other electronic suppliers impacting our customers' ability to ship their products, which in turn may adversely impact our sales to those customers;
|
|
|
·
|
costs and outcomes of any current or future tax audits or any litigation involving intellectual property, customers or other issues;
|
|
|
·
|
changes in tax regulations and policies in the U.S. and other countries in which we do business;
|
|
|
·
|
disruptions in our business or our customers' businesses due to terrorist activity, armed conflict, war, worldwide oil prices and supply, public health concerns or disruptions in the transportation system;
|
|
|
·
|
fluctuations in commodity prices;
|
|
|
·
|
general economic, industry or political conditions in the U.S. or internationally
.
|
|
|
·
|
the quality, performance, reliability, features, ease of use, pricing and diversity of our products;
|
|
|
·
|
our success in designing and manufacturing new products including those implementing new technologies;
|
|
|
·
|
the rate at which customers incorporate our products into their own applications;
|
|
|
·
|
product introductions by our competitors;
|
|
|
·
|
the number, nature and success of our competitors in a given market;
|
|
|
·
|
our ability to obtain adequate supplies of raw materials and other supplies at acceptable prices;
|
|
|
·
|
our ability to protect our products and processes by effective utilization of intellectual property rights;
|
|
|
·
|
our ability to remain price competitive against companies that have copied our proprietary product lines, especially in countries where intellectual property rights protection is difficult to achieve and maintain;
|
|
|
·
|
our ability to address the needs of our customers; and
|
|
|
·
|
general market and economic conditions.
|
|
|
·
|
proper new product selection;
|
|
|
·
|
timely completion and introduction of new product designs;
|
|
|
·
|
availability of development and support tools and collateral literature that make complex new products easy for engineers to understand and use; and
|
|
|
·
|
market acceptance of our customers' end products.
|
|
|
·
|
costs related to writing off the value of inventory of nonconforming products;
|
|
|
·
|
recalling nonconforming products;
|
|
|
·
|
providing support services, product replacements, or modifications to products and the defense of such claims;
|
|
|
·
|
diversion of resources from other projects;
|
|
|
·
|
lost revenue or a delay in the recognition of revenue due to cancellation of orders and unpaid receivables;
|
|
|
·
|
customer imposed fines or penalties for failure to meet contractual requirements; and
|
|
|
·
|
a requirement to pay damages.
|
|
|
·
|
political, social and economic instability;
|
|
|
·
|
public health conditions;
|
|
|
·
|
trade restrictions and changes in tariffs;
|
|
|
·
|
import and export license requirements and restrictions;
|
|
|
·
|
difficulties in staffing and managing international operations;
|
|
|
·
|
employment regulations;
|
|
|
·
|
disruptions in international transport or delivery;
|
|
|
·
|
difficulties in collecting receivables;
|
|
|
·
|
economic slowdown in the worldwide markets served by us; and
|
|
|
·
|
potentially adverse tax consequences.
|
|
|
·
|
quarterly variations in our operating results and the operating results of other technology companies;
|
|
|
·
|
actual or anticipated announcements of technical innovations or new products by us or our competitors;
|
|
|
·
|
changes in analysts' estimates of our financial performance or buy/sell recommendations;
|
|
|
·
|
changes in our financial guidance or our failure to meet such guidance;
|
|
|
·
|
any acquisitions we pursue or complete;
|
|
|
·
|
general conditions in the semiconductor industry; and
|
|
|
·
|
global economic and financial conditions.
|
|
Location
|
Approximate
Total Sq. Ft.
|
Uses
|
|
Chandler, Arizona
|
415,000
|
Executive and Administrative Offices; Wafer Probe; R&D Center; Sales and Marketing; and Computer and Service Functions
|
|
Tempe, Arizona
|
379,000
|
Wafer Fabrication (Fab 2); R&D Center; Administrative Offices; and Warehousing
|
|
Gresham, Oregon
|
826,500
|
Wafer Fabrication (Fab 4); R&D Center; Administrative Offices; and Warehousing
|
|
Chacherngsao, Thailand
|
489,000
|
Test and Assembly; Wafer Probe; Sample Center; Warehousing; and Administrative Offices
|
|
Bangalore, India
|
67,174
|
Research and Development; Marketing Support and Administrative Offices
|
|
Item 5
.
|
MARKET FOR REGISTRANT’S COMMON EQUITY AND RELATED STOCKHOLDER MATTERS
|
|
Fiscal 2010
|
High
|
Low
|
Fiscal 2009
|
High
|
Low
|
|
First Quarter
|
$23.86
|
$19.78
|
First Quarter
|
$38.13
|
$30.54
|
|
Second Quarter
|
$27.97
|
$21.84
|
Second Quarter
|
$33.97
|
$28.04
|
|
Third Quarter
|
$29.44
|
$23.96
|
Third Quarter
|
$28.82
|
$17.12
|
|
Fourth Quarter
|
$29.18
|
$25.81
|
Fourth Quarter
|
$21.78
|
$16.59
|
|
Cumulative Total Return
|
||||||
|
March 2005
|
March 2006
|
March 2007
|
March 2008
|
March 2009
|
March 2010
|
|
|
Microchip Technology Incorporated
|
100.00
|
142.09
|
143.06
|
136.41
|
93.18
|
130.69
|
|
S&P 500 Stock Index
|
100.00
|
111.73
|
124.95
|
118.60
|
73.43
|
109.97
|
|
Philadelphia Semiconductor Index
|
100.00
|
112.31
|
107.99
|
101.41
|
71.20
|
108.74
|
|
Fiscal 2010
|
Dividends per Common Share
|
Aggregate
Amount of
Dividend
Payment
|
Fiscal 2009
|
Dividends per Common Share
|
Aggregate
Amount of Dividend Payment
|
||||||||||||
|
First Quarter
|
$ | 0.339 | $ | 61,991 |
First Quarter
|
$ | 0.330 | $ | 60,977 | ||||||||
|
Second Quarter
|
0.339 | 62,083 |
Second Quarter
|
0.338 | 62,166 | ||||||||||||
|
Third Quarter
|
0.340 | 62,520 |
Third Quarter
|
0.339 | 61,690 | ||||||||||||
|
Fourth Quarter
|
0.341 | 62,963 |
Fourth Quarter
|
0.339 | 61,825 | ||||||||||||
|
Issuer Purchases of Equity Securities
|
||||||||||||||||
|
Period
|
(a) Total Number of
Shares Purchased
|
(b) Average Price Paid
per Share
|
(c) Total Number of Shares Purchased as Part of Publicly Announced Programs
|
(d) Maximum Number of Shares that May Yet Be Purchased Under the Programs
(1)
|
||||||||||||
|
January 1 – January 31, 2010
|
--- | $ | --- | --- | 2,460,002 | |||||||||||
|
February 1 – February 28, 2010
|
--- | $ | --- | --- | 2,460,002 | |||||||||||
|
March 1 – March 31, 2010
|
--- | $ | --- | --- | 2,460,002 | |||||||||||
|
Total
|
--- | $ | --- | --- | ||||||||||||
|
|
(1)
|
On December 11, 2007, our Board of Directors authorized the repurchase of up to 10 million shares of our common stock in open market or privately negotiated transactions. As of March 31, 2010, 2,460,002 shares of this authorization remained available to be purchased under this program. There is no expiration date associated with this program.
|
|
Item 6
.
|
SELECTED FINANCIAL DATA
|
|
Year ended March 31,
|
||||||||||||||||||||
|
2010
|
2009
|
2008
|
2007
|
2006
|
||||||||||||||||
|
Net sales
|
$ | 947,729 | $ | 903,297 | $ | 1,035,737 | $ | 1,039,671 | $ | 927,893 | ||||||||||
|
Cost of sales
|
413,487 | 386,793 | 410,799 | 414,915 | 377,016 | |||||||||||||||
|
Research and development
|
120,823 | 115,524 | 120,864 | 113,698 | 94,926 | |||||||||||||||
|
Selling, general and administrative
|
167,222 | 161,218 | 175,646 | 163,247 | 129,587 | |||||||||||||||
|
Special charges (1)
|
1,238 | 6,434 | 26,763 | --- | --- | |||||||||||||||
|
Operating income
|
244,959 | 233,328 | 301,665 | 347,811 | 326,364 | |||||||||||||||
|
Interest income
|
15,325 | 32,545 | 54,851 | 58,383 | 32,753 | |||||||||||||||
|
Interest expense
|
(31,150 | ) | (29,440 | ) | (9,495 | ) | (5,416 | ) | (1,967 | ) | ||||||||||
|
Other income (expense), net
|
8,679 | (4,354 | ) | 2,435 | 312 | 2,035 | ||||||||||||||
|
Income before income taxes
|
237,813 | 232,079 | 349,456 | 401,090 | 359,185 | |||||||||||||||
|
Income tax provision (benefit)
|
20,808 | (13,508 | ) | 52,663 | 44,061 | 116,816 | ||||||||||||||
|
Net income
|
$ | 217,005 | $ | 245,587 | $ | 296,793 | $ | 357,029 | $ | 242,369 | ||||||||||
|
Basic net income per common share
|
$ | 1.18 | $ | 1.34 | $ | 1.43 | $ | 1.66 | $ | 1.15 | ||||||||||
|
Diluted net income per common share
|
$ | 1.16 | $ | 1.31 | $ | 1.40 | $ | 1.62 | $ | 1.13 | ||||||||||
|
Dividends declared per common share
|
$ | 1.359 | $ | 1.346 | $ | 1.205 | $ | 0.965 | $ | 0.570 | ||||||||||
|
Basic common shares outstanding
|
183,642 | 183,158 | 207,220 | 215,498 | 210,104 | |||||||||||||||
|
Diluted common shares outstanding
|
187,339 | 186,788 | 212,048 | 220,848 | 215,024 | |||||||||||||||
|
March 31,
|
||||||||||||||||||||
|
2010
|
2009
|
2008
|
2007
|
2006
|
||||||||||||||||
|
Working capital
|
$ | 1,407,579 | $ | 1,587,144 | $ | 1,526,649 | $ | 828,817 | $ | 509,860 | ||||||||||
|
Total assets
|
2,516,313 | 2,405,711 | 2,496,031 | 2,269,541 | 2,350,596 | |||||||||||||||
|
Long-term obligations, less current portion
|
340,672 | 334,184 | 329,409 | --- | --- | |||||||||||||||
|
Stockholders’ equity
|
1,533,380 | 1,490,311 | 1,539,000 | 2,004,368 | 1,726,189 | |||||||||||||||
|
(1)
|
There were no special charges during the fiscal years ended March 31, 2007 and 2006. Discussions of the special charges for the fiscal years ended March 31, 2010, 2009 and 2008 are contained in Note 3 to our consolidated financial statements. The following table presents a summary of special charges for the five-year period ended March 31, 2010:
|
|
Year ended March 31,
|
||||||||||||||||||||
|
2010
|
2009
|
2008
|
2007
|
2006
|
||||||||||||||||
|
Patent licenses
|
$ | 1,238 | $ | 4,000 | $ | --- | $ | --- | $ | --- | ||||||||||
|
In-process research and development expenses
|
--- | 860 | --- | --- | --- | |||||||||||||||
|
Abandoned acquisition related expenses
|
--- | 1,574 | --- | --- | --- | |||||||||||||||
|
Loss on sale of Fab 3
|
--- | --- | 26,763 | --- | --- | |||||||||||||||
|
Totals
|
$ | 1,238 | $ | 6,434 | $ | 26,763 | $ | --- | $ | --- | ||||||||||
|
Item 7
.
|
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
|
·
|
The effects that adverse global economic conditions and fluctuations in the global credit and equity markets may have on our financial condition and results of operations;
|
|
·
|
The effects and amount of competitive pricing pressure on our product lines;
|
|
·
|
Our ability to moderate future average selling price declines;
|
|
·
|
The effect of product mix, capacity utilization, yields, and fixed cost absorption on gross margin;
|
|
·
|
The amount of changes in demand for our products and those of our customers;
|
|
·
|
The level of orders that will be received and shipped within a quarter;
|
|
·
|
The effect that distributor and customer inventory holding patterns will have on us;
|
|
·
|
Our belief that customers recognize our products and brand name and use distributors as an effective supply channel;
|
|
·
|
Our belief that deferred cost of sales will have low risk of material impairment;
|
|
·
|
Our belief that our direct sales personnel combined with our distributors provide an effective means of reaching our customer base;
|
|
·
|
Our ability to increase the proprietary portion of our analog and interface product lines and the effect of such an increase;
|
|
·
|
The impact of any supply disruption we may experience;
|
|
·
|
Our ability to effectively utilize our facilities at appropriate capacity levels and anticipated costs;
|
|
·
|
That we adjust capacity utilization to respond to actual and anticipated business and industry-related conditions;
|
|
·
|
That our existing facilities and planned expansion activities provide sufficient capacity to respond to increases in demand;
|
|
·
|
That manufacturing costs will be reduced by transition to advanced process technologies;
|
|
·
|
Our expectation that our wafer fabs will operate at high levels with no under-absorption of fixed costs;
|
|
·
|
Our ability to maintain manufacturing yields;
|
|
·
|
Continuing our investments in new and enhanced products;
|
|
·
|
Our ability to attract and retain qualified personnel;
|
|
·
|
The cost effectiveness of using our own assembly and test operations;
|
|
·
|
Our anticipated level of capital expenditures;
|
|
·
|
Continuation and amount of quarterly cash dividends;
|
|
·
|
The sufficiency of our existing sources of liquidity;
|
|
·
|
The impact of seasonality on our business;
|
|
·
|
The accuracy of our estimates used in valuing employee equity awards;
|
|
·
|
That the resolution of legal actions will not harm our business, and the accuracy of our assessment of the probability of loss and range of potential loss;
|
|
·
|
That the idling of assets will not impair the value of such assets;
|
|
·
|
The recoverability of our deferred tax assets;
|
|
·
|
The adequacy of our tax reserves to offset any potential tax liabilities, having the appropriate support for our income tax positions and the accuracy of our estimated tax rate;
|
|
·
|
Our belief that the expiration of any tax holidays will not have a material impact;
|
|
·
|
The accuracy of our estimates of the useful life and values of our property, assets, and other liabilities;
|
|
·
|
The adequacy of our patent strategy;
|
|
·
|
Our ability to obtain patents and intellectual property licenses and minimize the effects of litigation;
|
|
·
|
The level of risk we are exposed to for product liability claims;
|
|
·
|
The amount of labor unrest, public health issues, political instability, governmental interference and changes in general economic conditions that we experience;
|
|
·
|
The effect of fluctuations in market interest rates on income and/or cash flows;
|
|
·
|
The effect of fluctuations in currency rates;
|
|
·
|
Our ability to collect accounts receivable;
|
|
·
|
Our belief that our investments in student loan auction rate municipal bond offerings are of high credit quality;
|
|
·
|
Our ability to hold our fixed income investments and certain auction rate securities (ARS) until the market recovers, and the immaterial impact this will have on our liquidity;
|
|
·
|
Our belief that any future changes in the fair value of the ARS associated with the ARS rights agreement will be largely offset by changes in the fair value of the related rights without any significant net impact to our income statement;
|
|
·
|
The accuracy of our estimates used in valuing our available-for-sale securities.
|
|
·
|
Our belief that unrealized losses in our investment portfolio do not represent other-than-temporary impairment;
|
|
·
|
The accuracy of our estimation of the cost effectivity of our insurance coverage;
|
|
·
|
Our belief that our activities are conducted in compliance with various regulations not limited to environmental and export compliance;
|
|
·
|
Our ability and intent to settle the principal amount of the junior subordinated convertible debentures in cash; and
|
|
Year Ended March 31,
|
||||||||||||
|
2010
|
2009
|
2008
|
||||||||||
|
Net sales
|
100.0 | % | 100.0 | % | 100.0 | % | ||||||
|
Cost of sales
|
43.6 | 42.8 | 39.7 | |||||||||
|
Gross profit
|
56.4 | 57.2 | 60.3 | |||||||||
|
Research and development
|
12.8 | 12.8 | 11.7 | |||||||||
|
Selling, general and administrative
|
17.7 | 17.9 | 16.9 | |||||||||
|
Special charges
|
0.1 | 0.7 | 2.6 | |||||||||
|
Operating income
|
25.8 | % | 25.8 | % | 29.1 | % | ||||||
|
|
·
|
global economic conditions in the markets we serve;
|
|
|
·
|
semiconductor industry conditions;
|
|
|
·
|
inventory holding patterns of our customers;
|
|
|
·
|
increasing semiconductor content in our customers' products;
|
|
|
·
|
customers' increasing needs for the flexibility offered by our programmable solutions;
|
|
|
·
|
our new product offerings that have increased our served available market; and
|
|
|
·
|
continued market share gains.
|
|
Year Ended March 31,
|
||||||||||||||||||||||||
|
2010
|
2009
|
2008
|
||||||||||||||||||||||
|
Microcontrollers
|
$ | 767,723 | 81.0 | % | $ | 731,648 | 81.0 | % | $ | 832,921 | 80.4 | % | ||||||||||||
|
Memory products
|
80,158 | 8.5 | 89,336 | 9.9 | 120,280 | 11.6 | ||||||||||||||||||
|
Analog and interface products
|
99,848 | 10.5 | 82,313 | 9.1 | 82,536 | 8.0 | ||||||||||||||||||
|
Total Sales
|
$ | 947,729 | 100.0 | % | $ | 903,297 | 100.0 | % | $ | 1,035,737 | 100.0 | % | ||||||||||||
|
Year Ended March 31,
|
||||||||||||||||||||||||
|
2010
|
2009
|
2008
|
||||||||||||||||||||||
|
Americas
|
$ | 231,398 | 24.4 | % | $ | 228,922 | 25.3 | % | $ | 273,363 | 26.4 | % | ||||||||||||
|
Europe
|
237,354 | 25.1 | 257,407 | 28.5 | 308,171 | 29.8 | ||||||||||||||||||
|
Asia
|
478,977 | 50.5 | 416,968 | 46.2 | 454,203 | 43.8 | ||||||||||||||||||
|
Total Sales
|
$ | 947,729 | 100.0 | % | $ | 903,297 | 100.0 | % | $ | 1,035,737 | 100.0 | % | ||||||||||||
|
|
·
|
production levels being below the range of our normal capacity, such as in the second half of fiscal 2009 and the first half of fiscal 2010, resulting in under absorption of fixed costs; and
|
|
|
·
|
continual cost reductions in wafer fabrication and assembly and test manufacturing, such as new manufacturing technologies and more efficient manufacturing techniques.
|
|
|
·
|
inventory write-downs partially offset by sales of inventory that was previously written down;
|
|
|
·
|
lower depreciation as a percentage of cost of sales; and
|
|
|
·
|
fluctuations in the product mix of microcontrollers, proprietary and non-proprietary analog products and Serial EEPROM products resulting in lower overall average selling prices for our products.
|
|
Payments Due by Period
|
||||||||||||||||||||
|
Total
|
Less than
1 year
|
1 – 3 years
|
3 – 5 years
|
More than
5 years
|
||||||||||||||||
|
Operating lease obligations
|
$ | 11,858 | $ | 4,549 | $ | 5,164 | $ | 2,145 | $ | --- | ||||||||||
|
Capital purchase obligations (
1)
|
31,090 | 31,090 | --- | --- | --- | |||||||||||||||
|
Other purchase obligations and commitments (2)
|
3,139 | 1,950 | 1,189 | --- | --- | |||||||||||||||
|
2.125% junior convertible debentures – principal and interest (3)
|
1,827,122 | 24,438 | 48,875 | 48,875 | 1,704,934 | |||||||||||||||
|
Total contractual obligations (
4)
|
$ | 1,873,209 | $ | 62,027 | $ | 55,228 | $ | 51,020 | $ | 1,704,934 | ||||||||||
|
|
(1)
|
Capital purchase obligations represent commitments for construction or purchases of property, plant and equipment. These obligations were not recorded as liabilities on our balance sheet as of March 31, 2010, as we have not yet received the related goods or taken title to the property.
|
|
|
(2)
|
Other purchase obligations and commitments include payments due under various types of licenses.
|
|
|
(3)
|
For purposes of this table we have assumed that the principal of our convertible debentures will be paid on December 31, 2037.
|
|
|
(4)
|
Total contractual obligations do not include contractual obligations recorded on the balance sheet as current liabilities, or certain purchase obligations as discussed below. The contractual obligations also do not include amounts related to uncertain tax positions because reasonable estimates cannot be made.
|
|
Financial instruments maturing during the fiscal year ended March 31,
|
||||||||||||||||||||||||
|
2011
|
2012
|
2013
|
2014
|
2015
|
Thereafter
|
|||||||||||||||||||
|
Available-for-sale securities
|
$ | 309,744 | $ | 220,084 | $ | 470,529 | $ | --- | $ | --- | $ | 14,151 | ||||||||||||
|
Weighted-average yield rate
|
2.13 | % | 1.66 | % | 1.89 | % | --- | --- | 2.26 | % | ||||||||||||||
|
Item 8
.
|
FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
|
|
Item 9
.
|
CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND
|
|
|
FINANCIAL DISCLOSURE
|
|
Item 9A
.
|
CONTROLS AND PROCEDURES
|
|
Item 9B
.
|
OTHER INFORMATION
|
|
Item 10
.
|
DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
|
|
Item 11
.
|
EXECUTIVE COMPENSATION
|
|
Item 12
.
|
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS
|
|
Item 13
.
|
CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE
|
|
Item 14
.
|
PRINCIPAL ACCOUNTANT FEES AND SERVICES
|
|
Item 15
.
|
EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
|
|
Page No.
|
||
|
(1)
|
Financial Statements:
|
|
|
Report of Independent Registered Public Accounting Firm
|
F-1
|
|
|
Consolidated Balance Sheets as of March 31, 2010 and 2009
|
F-2
|
|
|
Consolidated Statements of Income for each of the three years in the
period ended March 31, 2010
|
F-3
|
|
|
Consolidated Statements of Cash Flows for each of the three years in the
period ended March 31, 2010
|
F-4
|
|
|
Consolidated Statements of Stockholders’ Equity for each of the three years in the period ended March 31, 2010
|
F-5
|
|
|
Notes to Consolidated Financial Statements
|
F-6
|
|
|
(2)
|
Financial Statement Schedules
|
|
|
(3)
|
The Exhibits filed with this Form 10-K or incorporated herein by reference are set
forth in the Exhibit Index beginning on page 47 hereof, which Exhibit Index is incorporated herein by this reference.
|
|
MICROCHIP TECHNOLOGY INCORPORATED
|
|
|
(Registrant)
|
|
|
Date: June 1, 2010
|
By:
/s/ Steve Sanghi
|
|
Steve Sanghi
|
|
|
President and Chief Executive Officer
|
|
Name and Signature
|
Title
|
Date
|
||
|
/s/ Steve Sanghi
|
Director, President and
Chief Executive Officer
|
June 1, 2010
|
||
|
Steve Sanghi
|
||||
|
/s/ Albert J. Hugo-Martinez
|
Director
|
June 1, 2010
|
||
|
Albert J. Hugo-Martinez
|
||||
|
/s/ L.B. Day
|
Director
|
June 1, 2010
|
||
|
L.B. Day
|
||||
|
/s/ Matthew W. Chapman
|
Director
|
June 1, 2010
|
||
|
Matthew W. Chapman
|
||||
|
/s/ Wade F. Meyercord
|
Director
|
June 1, 2010
|
||
|
Wade F. Meyercord
|
||||
|
/s/ J. Eric Bjornholt
|
Vice President and Chief Financial
|
June 1, 2010
|
||
|
J. Eric Bjornholt
|
Officer (Principal Financial
|
|||
|
and Accounting Officer)
|
||||
|
Incorporated by Reference
|
||||||
|
Exhibit
Number
|
Exhibit Description
|
Form
|
File Number
|
Exhibit
|
Filing
Date
|
Filed
Herewith
|
|
2.1
|
Purchase and Sale Agreement, dated as of July 18, 2002 between Registrant and Fujitsu Microelectronics, Inc.
|
8-K
|
000-21184
|
2.1
|
7/18/02
|
|
|
2.2
|
Agreement and Plan of Merger dated as of February 2, 2010 by and among Microchip Technology Incorporated, Sun Acquisition Corporation and Silicon Storage Technology, Inc.
|
10-Q
|
000-21184
|
2.1
|
2/9/10
|
|
|
2.3
|
Amendment No. 1 to Agreement and Plan of Merger by and among Microchip Technology Incorporated, Sun Acquisition Corporation and Silicon Storage Technology, Inc.
|
8-K
|
000-21184
|
2.1
|
2/23/09
|
|
|
2.4
|
Amendment No. 2 to Agreement and Plan of Merger by and among Microchip Technology Incorporated Sun Acquisition Corporation and Silicon Storage Technology, Inc.
|
8-K
|
000-21184
|
2.1
|
3/8/10
|
|
|
3.1
|
Restated Certificate of Incorporation of Registrant
|
10-Q
|
000-21184
|
3.1
|
11/12/02
|
|
|
3.2
|
Amended and Restated By-Laws of Registrant, as amended through January 29, 2007
|
10-Q
|
000-21184
|
3.1
|
2/6/07
|
|
|
4.3
|
Indenture, dated as of December 7, 2007, by and between Wells Fargo Bank, National Association, as Trustee, and Microchip Technology Incorporated
|
8-K
|
000-21184
|
4.1
|
12/7/07
|
|
|
4.4
|
Registration Rights Agreement, dated as of December 7, 2007, by and between J.P. Morgan Securities Inc. and Microchip Technology Incorporated
|
8-K
|
000-21184
|
4.2
|
12/7/07
|
|
|
10.1
|
Form of Indemnification Agreement between Registrant and its directors and certain of its officers
|
S-1
|
33-57960
|
10.1
|
2/5/93
|
|
|
10.2
|
*2004 Equity Incentive Plan as amended and restated by the Board on May 5, 2010
|
8-K
|
000-21184
|
10.1
|
8/19/09
|
|
|
10.3
|
*Form of Notice of Grant for 2004 Equity Incentive Plan (including Exhibit A Stock Option Agreement)
|
S-8
|
333-119939
|
4.5
|
10/25/04
|
|
|
10.4
|
Form of Notice of Grant (Foreign) for 2004 Equity Incentive Plan (including Exhibit A Stock Option Agreement (Foreign)
|
10-K
|
000-21184
|
10.4
|
5/23/05
|
|
|
10.5
|
*Restricted Stock Units Agreement (Domestic) for 2004 Equity Incentive Plan
|
10-Q
|
000-21184
|
10.3
|
11/7/07
|
|
|
10.6
|
Restricted Stock Units Agreement (Foreign) for 2004 Equity Incentive Plan
|
10-Q
|
000-21184
|
10.4
|
11/7/08
|
|
|
10.7
|
*Form of Notice of Grant of Restricted Stock Units for 2004 Equity Incentive Plan (including Exhibit A Restricted Stock Units Agreement)
|
10-K
|
000-21184
|
10.6
|
5/31/06
|
|
|
10.8
|
*1993 Stock Option Plan, as Amended through August 16, 2002
|
10-Q
|
000-21184
|
10.1
|
11/12/02
|
|
|
Incorporated by Reference
|
||||||
|
Exhibit
Number
|
Exhibit Description
|
Form
|
File Number
|
Exhibit
|
Filing
Date
|
Filed
Herewith
|
|
10.9
|
*Form of Notice of Grant For 1993 Stock Option Plan, with Exhibit A thereto, Form of Stock Option Agreement; and Exhibit B thereto, Form of Stock Purchase Agreement
|
S-8
|
333-872
|
10.6
|
1/23/96
|
|
|
10.10
|
*Microchip Technology Incorporated 2001 Employee Stock Purchase Plan as amended through August 15, 2003 (including Enrollment Form, Stock Purchase Agreement, and Change Form)
|
S-8
|
333-140773
|
4.4
|
2/16/07
|
|
|
10.11
|
*1997 Nonstatutory Stock Option Plan, as Amended Through March 3, 2003
|
10-K
|
000-21184
|
10.13
|
6/5/03
|
|
|
10.12
|
*Form of Notice of Grant For 1997 Nonstatutory Stock Option Plan, with Exhibit A thereto, Form of Stock Option Agreement
|
10-K
|
000-21184
|
10.17
|
5/27/98
|
|
|
10.13
|
Microchip Technology Incorporated International Employee Stock Purchase Plan, as amended through May 1, 2006
|
S-8
|
333-140773
|
4.1
|
2/16/07
|
|
|
10.14
|
Microchip Technology Incorporated International Stock Purchase Agreement (including attached Form of Enrollment Form)
|
S-8
|
333-140773
|
4.2
|
2/16/07
|
|
|
10.15
|
Form of Change Form for Microchip Technology Incorporated International Employee Stock Purchase Plan
|
S-8
|
333-140773
|
4.3
|
2/16/07
|
|
|
10.16
|
*Executive Management Incentive Compensation Plan
|
10-Q
|
000-21184
|
10.4
|
2/6/07
|
|
|
10.17
|
*Discretionary Executive Management Incentive Compensation Plan
|
10-Q
|
000-21184
|
10.5
|
2/6/07
|
|
|
10.18
|
*Management Incentive Compensation Plan amended by Board of Directors August 14, 2008
|
10-Q
|
000-21184
|
10.1
|
11/7/08
|
|
|
10.19
|
TelCom Semiconductor, Inc. 1994 Stock Option Plan and forms of agreements thereunder
|
S-8
|
333-53876
|
4.1
|
1/18/01
|
|
|
10.20
|
TelCom Semiconductor, Inc. 2000 Nonstatutory Stock Option Plan and forms of agreements used thereunder
|
S-8
|
333-53876
|
4.4
|
1/18/01
|
|
|
10.21
|
PowerSmart, Inc. 1998 Stock Incentive Plan, Including Forms of Incentive Stock Option Agreement and Nonqualified Stock Option Agreement
|
S-8
|
333-96791
|
4.1
|
7/19/02
|
|
|
10.22
|
*February 3, 2003 Amendment to the Adoption Agreement to the Microchip Technology Incorporated Supplemental Retirement Plan
|
10-K
|
000-21184
|
10.28
|
6/5/03
|
|
|
10.23
|
*Amendment dated August 29, 2001 to the Microchip Technology Incorporated Supplemental Retirement Plan
|
S-8
|
333-101696
|
4.1.2
|
12/6/02
|
|
|
Incorporated by Reference
|
||||||
|
Exhibit
Number
|
Exhibit Description
|
Form
|
File Number
|
Exhibit
|
Filing
Date
|
Filed
Herewith
|
|
10.24
|
*Amendment Dated December 9, 1999 to the Adoption Agreement to the Microchip Technology Incorporated Supplemental Retirement Plan
|
S-8
|
333-101696
|
4.1.4
|
12/6/02
|
|
|
10.25
|
*Adoption Agreement to the Microchip Technology Incorporated Supplemental Retirement Plan dated January 1, 1997
|
S-8
|
333-101696
|
4.1.3
|
12/6/02
|
|
|
10.26
|
*Microchip Technology Incorporated Supplemental Retirement Plan
|
S-8
|
333-101696
|
4.1.1
|
12/6/02
|
|
|
10.27
|
*Amendments to Supplemental Retirement Plan
|
10-Q
|
000-21184
|
10.1
|
2/9/06
|
|
|
10.28
|
*Change of Control Severance Agreement
|
8-K
|
000-21184
|
10.1
|
12/18/08
|
|
|
10.29
|
*Change of Control Severance Agreement
|
8-K
|
000-21184
|
10.2
|
12/18/08
|
|
|
10.30
|
Development Agreement dated as of August 29, 1997 by and between Registrant and the City of Chandler, Arizona
|
10-Q
|
000-21184
|
10.1
|
2/13/98
|
|
|
10.31
|
Addendum to Development Agreement by and between Registrant and the City of Tempe, Arizona, dated May 11, 2000
|
10-K
|
000-21184
|
10.14
|
5/15/01
|
|
|
10.32
|
Development Agreement dated as of July 17, 1997 by and between Registrant and the City of Tempe, Arizona
|
10-Q
|
000-21184
|
10.2
|
2/13/98
|
|
|
10.33
|
Amended Strategic Investment Program Contract dated as of June 8, 2009 between, Multnomah County, Oregon, City of Gresham, Oregon and Microchip Technology Incorporated
|
8-K
|
000-21184
|
10.1
|
6/11/09
|
|
|
21.1
|
Subsidiaries of Registrant
|
X
|
||||
|
23.1
|
Consent of Independent Registered Public Accounting Firm
|
X
|
||||
|
24.1
|
Power of Attorney re: Microchip Technology Incorporated, the Registrant
|
10-K | 000-21184 | 24.1 | 5/29/09 |
|
|
31.1
|
Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended (the Exchange Act)
|
X
|
||||
|
31.2
|
Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended (the Exchange Act)
|
X
|
||||
|
32
|
Certifications Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
X
|
||||
|
*Compensation plans or arrangements in which directors or executive officers are eligible to participate
|
||||||
|
Page Number
|
|
|
Report of Independent Registered Public Accounting Firm
|
F-1
|
|
Consolidated Balance Sheets as of March 31, 2010 and 2009
|
F-2
|
|
Consolidated Statements of Income for each of the three years in the period ended March 31, 2010
|
F-3
|
|
Consolidated Statements of Cash Flows for each of the three years in the period ended March 31, 2010
|
F-4
|
|
Consolidated Statements of Stockholders’ Equity for each of the three years in the period ended March 31, 2010
|
F-5
|
|
Notes to Consolidated Financial Statements
|
F-6
|
|
MICROCHIP TECHNOLOGY INCORPORATED AND SUBSIDIARIES
|
||||||||
|
|
||||||||
|
(in thousands, except share and per share amounts)
|
||||||||
|
ASSETS
|
||||||||
|
March 31,
|
||||||||
|
2010
|
As adjusted
2009
|
|||||||
|
(See Note 1)
|
||||||||
|
Cash and cash equivalents
|
$ | 492,130 | $ | 446,329 | ||||
|
Short-term investments
|
722,193 | 943,616 | ||||||
|
Accounts receivable, net
|
137,806 | 88,525 | ||||||
|
Inventories
|
116,579 | 131,510 | ||||||
|
Prepaid expenses
|
13,068 | 11,447 | ||||||
|
Deferred tax assets
|
77,810 | 69,626 | ||||||
|
Other current assets
|
51,383 | 51,736 | ||||||
|
Total current assets
|
1,610,969 | 1,742,789 | ||||||
|
Property, plant and equipment, net
|
493,039 | 531,687 | ||||||
|
Long-term investments
|
317,215 | 50,826 | ||||||
|
Goodwill
|
40,338 | 36,165 | ||||||
|
Intangible assets, net
|
35,527 | 25,718 | ||||||
|
Other assets
|
19,225 | 18,526 | ||||||
|
Total assets
|
$ | 2,516,313 | $ | 2,405,711 | ||||
|
LIABILITIES AND STOCKHOLDERS' EQUITY
|
||||||||
|
Accounts payable
|
$ | 44,238 | $ | 29,228 | ||||
|
Accrued liabilities
|
60,211 | 42,486 | ||||||
|
Deferred income on shipments to distributors
|
98,941 | 83,931 | ||||||
|
Total current liabilities
|
203,390 | 155,645 | ||||||
|
Junior convertible debentures
|
340,672 | 334,184 | ||||||
|
Long-term income tax payable
|
57,140 | 70,051 | ||||||
|
Deferred tax liability
|
376,713 | 351,686 | ||||||
|
Other long-term liabilities
|
5,018 | 3,834 | ||||||
|
Stockholders’ equity:
|
||||||||
|
Preferred stock, $0.001 par value; 5,000,000 shares authorized; no shares issued or outstanding.
|
--- | --- | ||||||
|
Common stock, $0.001 par value; 450,000,000 shares authorized; 218,789,994 shares issued and 185,329,144 shares outstanding at March 31, 2010; 218,789,994 shares issued and 182,769,124 shares outstanding at March 31, 2009.
|
185 | 183 | ||||||
|
Additional paid-in capital
|
1,276,822 | 1,281,936 | ||||||
|
Retained earnings
|
1,266,699 | 1,299,250 | ||||||
|
Accumulated other comprehensive income
|
3,032 | 4,312 | ||||||
|
Common stock held in treasury: 33,460,850 shares at March 31, 2010;and 36,020,870 shares at March 31, 2009.
|
(1,013,358 | ) | (1,095,370 | ) | ||||
|
Total stockholders’ equity
|
1,533,380 | 1,490,311 | ||||||
|
Total liabilities and stockholders’ equity
|
$ | 2,516,313 | $ | 2,405,711 | ||||
|
See accompanying notes to consolidated financial statements
|
||||||||
|
MICROCHIP TECHNOLOGY INCORPORATED AND SUBSIDIARIES
|
||||||||||||
|
|
||||||||||||
|
(in thousands, except per share amounts)
|
||||||||||||
|
Year ended March 31,
|
||||||||||||
|
2010
|
As adjusted
2009
|
As adjusted
2008
|
||||||||||
|
(See Note 1)
|
(See Note 1)
|
|||||||||||
|
Net sales
|
$ | 947,729 | $ | 903,297 | $ | 1,035,737 | ||||||
|
Cost of sales (1)
|
413,487 | 386,793 | 410,799 | |||||||||
|
Gross profit
|
534,242 | 516,504 | 624,938 | |||||||||
|
Operating expenses:
|
||||||||||||
|
Research and development (1)
|
120,823 | 115,524 | 120,864 | |||||||||
|
Selling, general and administrative (1)
|
167,222 | 161,218 | 175,646 | |||||||||
|
Special charges
|
1,238 | 6,434 | 26,763 | |||||||||
| 289,283 | 283,176 | 323,273 | ||||||||||
|
Operating income
|
244,959 | 233,328 | 301,665 | |||||||||
|
Other income (expense):
|
||||||||||||
|
Interest income
|
15,325 | 32,545 | 54,851 | |||||||||
|
Interest expense
|
(31,150 | ) | (29,440 | ) | (9,495 | ) | ||||||
|
Other, net
|
8,679 | (4,354 | ) | 2,435 | ||||||||
|
Income before income taxes
|
237,813 | 232,079 | 349,456 | |||||||||
|
Income tax provision (benefit)
|
20,808 | (13,508 | ) | 52,663 | ||||||||
|
Net income
|
$ | 217,005 | $ | 245,587 | $ | 296,793 | ||||||
|
Basic net income per common share
|
$ | 1.18 | $ | 1.34 | $ | 1.43 | ||||||
|
Diluted net income per common share
|
$ | 1.16 | $ | 1.31 | $ | 1.40 | ||||||
|
Dividends declared per common share
|
$ | 1.359 | $ | 1.346 | $ | 1.205 | ||||||
|
Basic common shares outstanding
|
183,642 | 183,158 | 207,220 | |||||||||
|
Diluted common shares outstanding
|
187,339 | 186,788 | 212,048 | |||||||||
|
(1) Includes share-based compensation expense as follows:
|
||||||||||||
|
Cost of sales
|
$ | 7,054 | $ | 5,845 | $ | 6,191 | ||||||
|
Research and development
|
12,194 | 10,866 | 10,695 | |||||||||
|
Selling, general and administrative
|
17,530 | 15,770 | 15,960 | |||||||||
|
See accompanying notes to consolidated financial statements
|
||||||||||||
|
MICROCHIP TECHNOLOGY INCORPORATED AND SUBSIDIARIES
|
||||||||||||
|
|
||||||||||||
|
(in thousands)
|
||||||||||||
|
Year ended March 31,
|
||||||||||||
|
2010
|
As adjusted
2009
|
As adjusted
2008
|
||||||||||
|
(See Note 1)
|
(See Note 1)
|
|||||||||||
|
Net income
|
$ | 217,005 | $ | 245,587 | $ | 296,793 | ||||||
|
Adjustments to reconcile net income to net cash provided by operating
|
||||||||||||
|
activities:
|
||||||||||||
|
Depreciation and amortization
|
90,057 | 96,046 | 100,076 | |||||||||
|
Deferred income taxes
|
18,621 | 20,527 | 8,987 | |||||||||
|
Share-based compensation expense related to equity incentive plans
|
36,778 | 32,481 | 32,846 | |||||||||
|
Tax benefit from equity incentive plans
|
3,709 | 7,584 | 21,914 | |||||||||
|
Excess tax benefit from share-based compensation
|
(2,094 | ) | (6,798 | ) | (21,184 | ) | ||||||
|
Convertible debt derivatives – revaluation and amortization
|
230 | (944 | ) | 128 | ||||||||
|
Amortization of junior convertible debenture issuance costs
|
215 | 215 | 68 | |||||||||
|
Gain on sale of assets
|
(100 | ) | (100 | ) | (937 | ) | ||||||
|
Special charges
|
1,238 | 860 | 26,763 | |||||||||
|
Sales/(purchases) of trading securities
|
86,970 | (73,510 | ) | (12,133 | ) | |||||||
|
(Gain) loss on trading securities
|
(7,425 | ) | 6,332 | --- | ||||||||
|
Unrealized impairment loss on available-for-sale investments
|
4,750 | 3,560 | 2,439 | |||||||||
|
Changes in operating assets and liabilities:
|
||||||||||||
|
(Increase) decrease in accounts receivable
|
(49,078 | ) | 50,832 | (13,760 | ) | |||||||
|
Decrease (increase) in inventories
|
15,239 | (4,110 | ) | (2,902 | ) | |||||||
|
Increase (decrease) in deferred income on shipments to distributors
|
15,010 | (11,510 | ) | 4,078 | ||||||||
|
Increase (decrease) in accounts payable and accrued liabilities
|
29,583 | (25,097 | ) | 12,080 | ||||||||
|
Change in other assets and liabilities
|
(8,661 | ) | (33,302 | ) | (7,949 | ) | ||||||
|
Net cash provided by operating activities
|
452,047 | 308,653 | 447,307 | |||||||||
|
Cash flows from investing activities:
|
||||||||||||
|
Purchases of available-for-sale investments
|
(1,576,044 | ) | (2,479,175 | ) | (1,857,964 | ) | ||||||
|
Sales and maturities of available-for-sale investments
|
1,502,127 | 2,583,152 | 1,959,210 | |||||||||
|
Investment in Silicon Storage Technology, Inc.
|
(58,402 | ) | --- | --- | ||||||||
|
Investment in other assets
|
(15,439 | ) | (21,600 | ) | (5,012 | ) | ||||||
|
Proceeds from sale of Fab 3
|
--- | --- | 27,523 | |||||||||
|
Proceeds from sale of assets
|
100 | 166 | 1,725 | |||||||||
|
Capital expenditures
|
(47,604 | ) | (102,370 | ) | (69,827 | ) | ||||||
|
Net cash (used in) provided by investing activities
|
(195,262 | ) | (19,827 | ) | 55,655 | |||||||
|
Cash flows from financing activities:
|
||||||||||||
|
Payment of cash dividend
|
(249,556 | ) | (246,657 | ) | (251,959 | ) | ||||||
|
Repurchase of common stock
|
--- | (123,929 | ) | (1,138,040 | ) | |||||||
|
Proceeds from issuance of junior convertible debentures, net of issuance costs
|
--- | --- | 1,127,000 | |||||||||
|
Proceeds from sale of common stock
|
36,478 | 33,555 | 59,112 | |||||||||
|
Excess tax benefit from share-based compensation
|
2,094 | 6,798 | 21,184 | |||||||||
|
Net cash used in financing activities
|
(210,984 | ) | (330,233 | ) | (182,703 | ) | ||||||
|
Net increase (decrease) in cash and cash equivalents
|
45,801 | (41,407 | ) | 320,259 | ||||||||
|
Cash and cash equivalents at beginning of year
|
446,329 | 487,736 | 167,477 | |||||||||
|
Cash and cash equivalents at end of year
|
$ | 492,130 | $ | 446,329 | $ | 487,736 | ||||||
|
See accompanying notes to consolidated financial statements
|
||||||||||||
|
MICROCHIP TECHNOLOGY INCORPORATED AND SUBSIDIARIES
|
|||||||||||||||||||||||||||
|
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
|
|||||||||||||||||||||||||||
|
(in thousands)
|
|||||||||||||||||||||||||||
|
Common Stock and
Additional Paid-in
Capital
|
Common Stock
Held
in Treasury
|
Accumulated
Other
Comprehensive
Income (Loss)
|
|||||||||||||||||||||||||
|
Retained
Earnings
|
Net
Stockholders’
Equity
|
||||||||||||||||||||||||||
|
Shares
|
Amount
|
Shares
|
Amount
|
||||||||||||||||||||||||
|
Balance at March 31, 2007
|
217,440 | $ | 756,051 | --- | $ | --- | $ | (7,169 | ) | $ | 1,255,486 | $ | 2,004,368 | ||||||||||||||
|
Components of other comprehensive income:
|
|||||||||||||||||||||||||||
|
Net income
|
--- | --- | --- | --- | --- | 296,793 | 296,793 | ||||||||||||||||||||
|
Net unrealized gains on available-for-sale investments, net of $2,293 of tax
|
--- | --- | --- | --- | 9,677 | --- | 9,677 | ||||||||||||||||||||
|
Total comprehensive income
|
306,470 | ||||||||||||||||||||||||||
|
Issuances from equity incentive plans
|
2,983 | 47,406 | --- | --- | --- | --- | 47,406 | ||||||||||||||||||||
|
Employee stock purchase plan
|
419 | 11,706 | --- | --- | --- | --- | 11,706 | ||||||||||||||||||||
|
Purchase of treasury stock
|
--- | --- | 36,503 | (1,138,040 | ) | --- | --- | (1,138,040 | |||||||||||||||||||
|
Treasury stock used for new issuances
|
(2,052 | ) | (76,377 | ) | (2,052 | ) | 76,377 | --- | --- | --- | |||||||||||||||||
|
Tax benefit from equity incentive plans
|
--- | 21,914 | --- | --- | --- | --- | 21,914 | ||||||||||||||||||||
|
Share-based compensation
|
--- | 33,403 | --- | --- | --- | --- | 33,403 | ||||||||||||||||||||
|
Equity component related to the issuance of the Convertible Debentures (See Note 1)
|
--- | 503,732 | --- | --- | --- | --- | 503,732 | ||||||||||||||||||||
|
Cash dividend
|
--- | --- | --- | --- | --- | (251,959 | ) | (251,959 | |||||||||||||||||||
|
Balance at March 31, 2008 (As adjusted, see Note 1)
|
218,790 | 1,297,835 | 34,451 | (1,061,663 | ) | 2,508 | 1,300,320 | 1,539,000 | |||||||||||||||||||
|
Components of other comprehensive income:
|
|||||||||||||||||||||||||||
|
Net income
|
--- | --- | --- | --- | --- | 245,587 | 245,587 | ||||||||||||||||||||
|
Net unrealized gains on available-for-sale investments, net of $1,669 of tax
|
--- | --- | --- | --- | 1,804 | --- | 1,804 | ||||||||||||||||||||
|
Total comprehensive income
|
247,391 | ||||||||||||||||||||||||||
|
Issuances from equity incentive plans
|
1,917 | 22,767 | --- | --- | --- | --- | 22,767 | ||||||||||||||||||||
|
Employee stock purchase plan
|
545 | 10,788 | --- | --- | --- | --- | 10,788 | ||||||||||||||||||||
|
Purchase of treasury stock
|
--- | --- | 4,032 | (123,929 | ) | --- | --- | (123,929 | |||||||||||||||||||
|
Treasury stock used for new issuances
|
(2,462 | ) | (90,222 | ) | (2,462 | ) | 90,222 | --- | --- | --- | |||||||||||||||||
|
Tax benefit from equity incentive plans
|
--- | 7,584 | --- | --- | --- | --- | 7,584 | ||||||||||||||||||||
|
Share-based compensation
|
--- | 33,367 | --- | --- | --- | --- | 33,367 | ||||||||||||||||||||
|
Cash dividend
|
--- | --- | --- | --- | --- | (246,657 | ) | (246,657 | |||||||||||||||||||
|
Balance at March 31, 2009 (As adjusted, see Note 1)
|
218,790 | 1,282,119 | 36,021 | (1,095,370 | ) | 4,312 | 1,299,250 | 1,490,311 | |||||||||||||||||||
|
Components of other comprehensive income:
|
|||||||||||||||||||||||||||
|
Net income
|
--- | --- | --- | --- | --- | 217,005 | 217,005 | ||||||||||||||||||||
|
Net unrealized losses on available-for-sale investments, net of $1,778 of tax
|
--- | --- | --- | --- | (1,280 | ) | --- | (1,280 | |||||||||||||||||||
|
Total comprehensive income
|
215,725 | ||||||||||||||||||||||||||
|
Issuances from equity incentive plans
|
1,955 | 27,108 | --- | --- | --- | --- | 27,108 | ||||||||||||||||||||
|
Employee stock purchase plan
|
605 | 9,370 | --- | --- | --- | --- | 9,370 | ||||||||||||||||||||
|
Treasury stock used for new issuances
|
(2,560 | ) | (82,012 | ) | (2,560 | ) | 82,012 | --- | --- | --- | |||||||||||||||||
|
Tax benefit from equity incentive plans
|
--- | 3,709 | --- | --- | --- | --- | 3,709 | ||||||||||||||||||||
|
Share-based compensation
|
--- | 36,713 | --- | --- | --- | --- | 36,713 | ||||||||||||||||||||
|
Cash dividend
|
--- | --- | --- | --- | --- | (249,556 | ) | (249,556 | |||||||||||||||||||
|
Balance at March 31, 2010
|
218,790 | $ | 1,277,007 | 33,461 | $ | (1,013,358 | ) | $ | 3,032 | $ | 1,266,699 | $ | 1,533,380 | ||||||||||||||
|
See accompanying notes to consolidated financial statements
|
|||||||||||||||||||||||||||
|
1.
|
SIGNIFICANT ACCOUNTING POLICIES
|
|
Condensed Consolidated Statements of Income:
|
||||||||||||||||
|
Year Ended
March 31, 2009
|
Year Ended
March 31, 2008
|
|||||||||||||||
|
As Reported
|
As Adjusted
|
As Reported
|
As Adjusted
|
|||||||||||||
|
Interest expense
|
$ | (24,269 | ) | $ | (29,440 | ) | $ | (7,966 | ) | $ | (9,495 | ) | ||||
|
Income before income taxes
|
$ | 237,250 | $ | 232,079 | $ | 350,985 | $ | 349,456 | ||||||||
|
Income tax (benefit) provision
|
$ | (11,570 | ) | $ | (13,508 | ) | $ | 53,237 | $ | 52,663 | ||||||
|
Net income
|
$ | 248,820 | $ | 245,587 | $ | 297,748 | $ | 296,793 | ||||||||
|
Basic net income per common share
|
$ | 1.36 | $ | 1.34 | $ | 1.44 | $ | 1.43 | ||||||||
|
Diluted net income per common share
|
$ | 1.33 | $ | 1.31 | $ | 1.40 | $ | 1.40 | ||||||||
|
Condensed Consolidated Balance Sheet:
|
||||||||
|
March 31, 2009
|
||||||||
|
As Reported
|
As Adjusted
|
|||||||
|
Other assets
|
$ | 34,254 | $ | 18,526 | ||||
|
Total assets
|
$ | 2,421,439 | $ | 2,405,711 | ||||
|
Junior convertible debentures
|
$ | 1,149,184 | $ | 334,184 | ||||
|
Deferred tax liability
|
$ | 51,959 | $ | 351,686 | ||||
|
Additional paid-in capital
|
$ | 778,204 | $ | 1,281,936 | ||||
|
Retained earnings
|
$ | 1,303,437 | $ | 1,299,250 | ||||
|
Total stockholders' equity
|
$ | 990,766 | $ | 1,490,311 | ||||
|
Total liabilities and stockholders' equity
|
$ | 2,421,439 | $ | 2,405,711 | ||||
|
3.
|
SPECIAL CHARGES
|
|
4.
|
INVESTMENTS
|
|
Available-for-sale Securities
|
||||||||||||||||
|
Adjusted
Cost
|
Gross Unrealized Gains
|
Gross Unrealized Losses
|
Estimated
Fair Value
|
|||||||||||||
|
Government agency bonds
|
$ | 389,801 | $ | 215 | $ | 622 | $ | 389,394 | ||||||||
|
Municipal bonds
|
156,415 | 1,290 | --- | 157,705 | ||||||||||||
|
Auction rate securities (ARS)
|
14,151 | --- | --- | 14,151 | ||||||||||||
|
Marketable equity securities
|
58,402 | --- | --- | 58,402 | ||||||||||||
|
Corporate bonds
|
392,108 | 2,983 | 235 | 394,856 | ||||||||||||
| $ | 1,010,877 | $ | 4,488 | $ | 857 | $ | 1,014,508 | |||||||||
|
Trading Securities
|
||||||||||||||||
|
Adjusted
Cost
|
Gross Unrealized Gains
|
Gross Unrealized Losses
|
Estimated
Fair Value
|
|||||||||||||
|
ARS
|
$ | 23,086 | $ | --- | $ | --- | $ | 23,086 | ||||||||
|
Put option on ARS
|
1,814 | --- | --- | 1,814 | ||||||||||||
| $ | 24,900 | $ | --- | $ | --- | $ | 24,900 | |||||||||
|
Available-for-sale Securities
|
||||||||||||||||
|
Adjusted
Cost
|
Gross
Unrealized Gains
|
Gross
Unrealized Losses
|
Estimated
Fair Value
|
|||||||||||||
|
Available-for-sale
|
||||||||||||||||
|
Due in one year or less
|
$ | 308,020 | $ | 1,743 | $ | 19 | $ | 309,744 | ||||||||
|
Due after one year and through five years
|
688,706 | 2,745 | 838 | 690,613 | ||||||||||||
|
Due after five years and through ten years
|
--- | --- | --- | --- | ||||||||||||
|
Due after ten years
|
14,151 | --- | --- | 14,151 | ||||||||||||
| $ | 1,010,877 | $ | 4,488 | $ | 857 | $ | 1,014,508 | |||||||||
|
Available-for-sale Securities
|
||||||||||||||||
|
Adjusted
Cost
|
Gross
Unrealized Gains
|
Gross
Unrealized Losses
|
Estimated
Fair Value
|
|||||||||||||
|
Government agency bonds
|
$ | 469,815 | $ | 960 | $ | --- | $ | 470,775 | ||||||||
|
ARS
|
18,901 | --- | --- | 18,901 | ||||||||||||
|
Municipal bonds
|
356,520 | 6,159 | --- | 362,679 | ||||||||||||
|
Corporate bonds
|
20,000 | --- | 430 | 19,570 | ||||||||||||
| $ | 865,236 | $ | 7,119 | $ | 430 | $ | 871,925 | |||||||||
|
5.
|
ACCOUNTS RECEIVABLE
|
|
March 31,
|
||||||||
|
2010
|
2009
|
|||||||
|
Trade accounts receivable
|
$ | 140,340 | $ | 91,325 | ||||
|
Other
|
575 | 376 | ||||||
| 140,915 | 91,701 | |||||||
|
Less allowance for doubtful accounts
|
3,109 | 3,176 | ||||||
| $ | 137,806 | $ | 88,525 | |||||
|
March 31,
|
||||||||
|
2010
|
2009
|
|||||||
|
Raw materials
|
$ | 4,912 | $ | 3,693 | ||||
|
Work in process
|
100,607 | 114,676 | ||||||
|
Finished goods
|
11,060 | 13,141 | ||||||
| $ | 116,579 | $ | 131,510 | |||||
|
|
Level 1 – Observable inputs such as quoted prices in active markets;
|
|
|
Level 2 – Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and
|
|
|
Level 3 – Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.
|
|
Quoted Prices in Active Markets for Identical Instruments
(Level 1)
|
Significant
Other
Observable
Inputs
(Level 2)
|
Significant
Unobservable
Inputs
(Level 3)
|
Total
Balance
|
|||||||||||||
|
Assets
|
||||||||||||||||
|
Money market fund deposits
|
$ | 206,376 | $ | --- | $ | --- | $ | 206,376 | ||||||||
|
Deposit accounts
|
--- | 285,754 | --- | 285,754 | ||||||||||||
|
Government agency bonds
|
--- | 389,394 | --- | 389,394 | ||||||||||||
|
Municipal bonds
|
--- | 157,705 | --- | 157,705 | ||||||||||||
|
ARS
|
--- | --- | 37,237 | 37,237 | ||||||||||||
|
Put option on ARS
|
--- | --- | 1,814 | 1,814 | ||||||||||||
|
Corporate bonds
|
--- | 394,856 | --- | 394,856 | ||||||||||||
|
Marketable equity securities
|
58,402 | --- | --- | 58,402 | ||||||||||||
|
Total assets measured at fair value
|
$ | 264,778 | $ | 1,227,709 | $ | 39,051 | $ | 1,531,538 | ||||||||
|
Year Ended
March 31, 2010
|
||||
|
Balance at March 31, 2009
|
$ | 50,826 | ||
|
Securities redeemed at par
|
(7,025 | ) | ||
|
Impairment losses included in other, net
|
(4,750 | ) | ||
|
Balance at March 31, 2010
|
$ | 39,051 | ||
|
Quoted Prices
in Active
Markets for
Identical
Instruments
(Level 1)
|
Significant
Other
Observable
Inputs
(Level 2)
|
Significant
Unobservable
Inputs
(Level 3)
|
Total
Balance
|
|||||||||||||
|
Assets
|
||||||||||||||||
|
Cash and cash equivalents
|
$ | 206,376 | $ | 285,754 | $ | --- | $ | 492,130 | ||||||||
|
Short-term investments
|
58,402 | 638,891 | 24,900 | 722,193 | ||||||||||||
|
Long-term investments
|
--- | 303,064 | 14,151 | 317,215 | ||||||||||||
|
Total assets measured at fair value
|
$ | 264,778 | $ | 1,227,709 | $ | 39,051 | $ | 1,531,538 | ||||||||
|
March 31,
|
||||||||
|
2010
|
2009
|
|||||||
|
Land
|
$ | 39,671 | $ | 39,671 | ||||
|
Building and building improvements
|
349,964 | 334,717 | ||||||
|
Machinery and equipment
|
1,190,548 | 1,148,588 | ||||||
|
Projects in process
|
84,254 | 114,478 | ||||||
| 1,664,437 | 1,637,454 | |||||||
|
Less accumulated depreciation and amortization
|
1,171,398 | 1,105,767 | ||||||
| $ | 493,039 | $ | 531,687 | |||||
|
March 31, 2010
|
||||||||||||
|
Gross
Amount
|
Accumulated
Amortization
|
Net
Amount
|
||||||||||
|
Developed technology
|
$ | 49,009 | $ | (17,979 | ) | $ | 31,030 | |||||
|
In-process technology
|
2,900 | --- | 2,900 | |||||||||
|
Distribution rights
|
5,236 | (3,639 | ) | 1,597 | ||||||||
| $ | 57,145 | $ | (21,618 | ) | $ | 35,527 | ||||||
|
March 31, 2009
|
||||||||||||
|
Gross
Amount
|
Accumulated
Amortization
|
Net
Amount
|
||||||||||
|
Developed technology
|
$ | 38,419 | $ | (14,805 | ) | $ | 23,614 | |||||
|
Distribution rights
|
5,236 | (3,132 | ) | 2,104 | ||||||||
| $ | 43,655 | $ | (17,937 | ) | $ | 25,718 | ||||||
|
Year Ending
March 31,
|
Projected
Amortization Expense
|
|
2011
|
$ 4,455
|
|
2012
|
5,573
|
|
2013
|
5,633
|
|
2014
|
4,968
|
|
2015
|
4,931
|
|
Goodwill, net
|
||||
|
March 31, 2008
|
$ | 31, 886 | ||
|
Additions due to business combinations
|
4,279 | |||
|
March 31, 2009
|
$ | 36,165 | ||
|
Additions due to business combination
|
4,173 | |||
|
March 31, 2010
|
$ | 40,338 | ||
|
Balance as of April 1, 2009
|
$ | 70,051 | ||
|
Decreases related to prior year tax positions
|
(25,492 | ) | ||
|
Increases related to current year tax positions
|
11,332 | |||
|
Increases related to prior year tax positions
|
1,249 | |||
|
Balance as of March 31, 2010
|
$ | 57,140 |
|
Year Ended March 31,
|
||||||||||||
|
2010
|
2009
|
2008
|
||||||||||
|
Current (benefit) expense:
|
||||||||||||
|
Federal
|
$ | (4,358 | ) | $ | (38,836 | ) | $ | 31,202 | ||||
|
State
|
(436 | ) | (3,888 | ) | 3,124 | |||||||
|
Foreign
|
6,981 | 8,689 | 9,350 | |||||||||
|
Total current
|
2,187 | (34,035 | ) | 43,676 | ||||||||
|
Deferred expense (benefit):
|
||||||||||||
|
Federal
|
16,663 | 19,476 | 6,814 | |||||||||
|
State
|
1,668 | 1,950 | 682 | |||||||||
|
Foreign
|
290 | (899 | ) | 1,491 | ||||||||
|
Total deferred
|
18,621 | 20,527 | 8,987 | |||||||||
| $ | 20,808 | $ | (13,508 | ) | $ | 52,663 | ||||||
|
Year Ended March 31,
|
||||||||||||
|
2010
|
2009
|
2008
|
||||||||||
|
Computed expected income tax provision
|
$ | 83,235 | $ | 81,228 | $ | 122,310 | ||||||
|
State income taxes, net of federal benefits
|
915 | 1,295 | 2,674 | |||||||||
|
Domestic production activities/foreign export sales benefit
|
--- | --- | (257 | ) | ||||||||
|
Research and development tax credits
|
(1,500 | ) | (2,732 | ) | (2,625 | ) | ||||||
|
Foreign income taxed at lower than the federal rate
|
(53,390 | ) | (43,452 | ) | (58,475 | ) | ||||||
|
Tax benefit from IRS settlement
|
(8,452 | ) | (16,880 | ) | --- | |||||||
|
Release of tax reserves
|
--- | (32,967 | ) | (10,964 | ) | |||||||
| $ | 20,808 | $ | (13,508 | ) | $ | 52,663 | ||||||
|
March 31,
|
||||||||
|
2010
|
2009
|
|||||||
|
Deferred tax assets:
|
||||||||
|
Deferred intercompany profit
|
$ | 7,711 | $ | 10,048 | ||||
|
Deferred income on shipments to distributors
|
24,531 | 20,596 | ||||||
|
Inventory valuation
|
842 | 2,548 | ||||||
|
Net operating loss carryforward
|
2,966 | 3,079 | ||||||
|
Share-based compensation
|
30,316 | 23,938 | ||||||
|
Accrued expenses and other
|
11,444 | 9,417 | ||||||
|
Gross deferred tax assets
|
77,810 | 69,626 | ||||||
|
Deferred tax liabilities:
|
||||||||
|
Property, plant and equipment, principally
due to differences in depreciation
|
(3,861 | ) | (7,997 | ) | ||||
|
Junior convertible debentures
|
(372,252 | ) | (341,259 | ) | ||||
|
Other
|
(600 | ) | (2,430 | ) | ||||
|
Gross deferred tax liability
|
(376,713 | ) | (351,686 | ) | ||||
|
Net deferred tax liability
|
$ | (298,903 | ) | $ | (282,060 | ) | ||
|
12.
|
CONTINGENCIES
|
|
13.
|
STOCKHOLDERS' EQUITY
|
|
14.
|
EMPLOYEE BENEFIT PLANS
|
|
15.
|
EQUITY INCENTIVE PLANS
|
|
Year Ended March 31,
|
||||||||||||
|
2010
|
2009
|
2008
|
||||||||||
|
Cost of sales
|
$ | 7,054 | (1) | $ | 5,845 | (1) | $ | 6,191 | (1) | |||
|
Research and development
|
12,194 | 10,866 | 10,695 | |||||||||
|
Selling, general and administrative
|
17,530 | 15,770 | 15,960 | |||||||||
|
Pre-tax effect of share-based compensation
|
36,778 | 32,481 | 32,846 | |||||||||
|
Income tax benefit
|
(4,563 | ) | (5,277 | ) | (6,395 | ) | ||||||
|
Net income effect of share-based compensation
|
$ | 32,215 | $ | 27,204 | $ | 26,451 | ||||||
|
Number of Shares
|
||||
|
Nonvested shares at March 31, 2007
|
1,687,443 | |||
|
Granted
|
1,084,690 | |||
|
Forfeited/expired
|
(174,755 | ) | ||
|
Vested
|
(132,813 | ) | ||
|
Nonvested shares at March 31, 2008
|
2,464,565 | |||
|
Granted
|
1,876,738 | |||
|
Forfeited/expired
|
(293,573 | ) | ||
|
Vested
|
(445,958 | ) | ||
|
Nonvested shares at March 31, 2009
|
3,601,772 | |||
|
Granted
|
1,846,241 | |||
|
Forfeited/expired
|
(120,198 | ) | ||
|
Vested
|
(689,867 | ) | ||
|
Nonvested shares at March 31, 2010
|
4,637,948 | |||
|
Number of
Shares
|
Weighted
Average Exercise
Price per Share
|
|||||||
|
Outstanding at March 31, 2007
|
14,740,546 | $ | 21.88 | |||||
|
Granted
|
31,597 | 37.23 | ||||||
|
Exercised
|
(2,850,155 | ) | 16.66 | |||||
|
Canceled
|
(189,603 | ) | 25.17 | |||||
|
Outstanding at March 31, 2008
|
11,732,385 | 23.14 | ||||||
|
Granted
|
24,000 | 33.90 | ||||||
|
Exercised
|
(1,573,183 | ) | 16.33 | |||||
|
Canceled
|
(101,669 | ) | 26.27 | |||||
|
Outstanding at March 31, 2009
|
10,081,533 | 24.20 | ||||||
|
Granted
|
12,000 | 27.03 | ||||||
|
Exercised
|
(1,492,866 | ) | 22.03 | |||||
|
Canceled
|
(140,888 | ) | 27.79 | |||||
|
Outstanding at March 31, 2010
|
8,459,779 | $ | 24.52 | |||||
|
Range of
Exercise Prices
|
Number
Outstanding
|
Weighted
Average
Exercise Price
|
Weighted
Average
Remaining Life
(in years)
|
Number
Exercisable
|
Weighted
Average
Exercise Price
|
|||||||||||||||||
| $ | 10.04- $17.85 | 715,370 | $ | 16.10 | 0.98 | 715,370 | $ | 16.10 | ||||||||||||||
| 17.86 - 18.48 | 1,054,311 | 18.48 | 3.01 | 1,054,311 | 18.48 | |||||||||||||||||
| 18.49 - 24.04 | 891,916 | 22.86 | 2.33 | 891,916 | 22.86 | |||||||||||||||||
| 24.05 - 25.26 | 222,053 | 24.51 | 1.73 | 222,053 | 24.51 | |||||||||||||||||
| 25.27 - 25.29 | 1,441,614 | 25.29 | 4.98 | 1,439,954 | 25.29 | |||||||||||||||||
| 25.30 - 27.03 | 653,827 | 26.22 | 3.88 | 648,827 | 26.21 | |||||||||||||||||
| 27.04 - 27.05 | 1,269,900 | 27.05 | 3.98 | 1,269,900 | 27.05 | |||||||||||||||||
| 27.06 - 27.15 | 1,373,834 | 27.15 | 2.01 | 1,373,833 | 27.15 | |||||||||||||||||
| 27.16 - 37.46 | 812,954 | 30.11 | 3.94 | 793,281 | 29.95 | |||||||||||||||||
| 37.47 - 37.84 | 24,000 | 37.84 | 7.38 | 24,000 | 37.84 | |||||||||||||||||
| 8,459,779 | $ | 24.52 | 3.22 | 8,433,445 | $ | 24.49 | ||||||||||||||||
|
Year Ended March 31,
|
||||||||||||
|
2010
|
2009
|
2008
|
||||||||||
|
Expected term (in years)
|
6.50 | 6.50 | 6.50 | |||||||||
|
Volatility
|
36 | % | 43 | % | 39 | % | ||||||
|
Risk-free interest rate
|
2.57 | % | 3.14 | % | 3.92 | % | ||||||
|
Dividend yield
|
5.00 | % | 4.00 | % | 3.31 | % | ||||||
|
16.
|
LEASE COMMITMENTS
|
|
Year Ending
March 31,
|
Amount
|
|||
|
2011
|
$ | 4,549 | ||
|
2012
|
3,315 | |||
|
2013
|
1,849 | |||
|
2014
|
1,102 | |||
|
2015
|
1,043 | |||
|
Total minimum payments
|
$ | 11,858 | ||
|
17.
|
GEOGRAPHIC AND OTHER INFORMATION
|
|
March 31,
|
||||||||
|
2010
|
2009
|
|||||||
|
United States
|
$ | 332,920 | $ | 368,149 | ||||
|
Thailand
|
147,732 | 152,359 | ||||||
|
Various other countries
|
12,387 | 11,179 | ||||||
|
Total long-lived assets
|
$ | 493,039 | $ | 531,687 | ||||
|
18.
|
FAIR VALUE OF FINANCIAL INSTRUMENTS
|
|
19.
|
DERIVATIVE INSTRUMENTS
|
|
20.
|
NET INCOME PER COMMON SHARE
|
|
Year Ended March 31,
|
||||||||||||
|
2010
|
2009
|
2008
|
||||||||||
|
Net income
|
$ | 217,005 | $ | 245,587 | $ | 296,793 | ||||||
|
Weighted average common shares outstanding
|
183,642 | 183,158 | 207,220 | |||||||||
|
Dilutive effect of stock options and RSUs
|
3,697 | 3,336 | 4,828 | |||||||||
|
Dilutive effect of convertible debt
|
--- | 294 | --- | |||||||||
|
Weighted average common and common equivalent shares outstanding
|
187,339 | 186,788 | 212,048 | |||||||||
|
Basic net income per common share
|
$ | 1.18 | $ | 1.34 | $ | 1.43 | ||||||
|
Diluted net income per common share
|
$ | 1.16 | $ | 1.31 | $ | 1.40 | ||||||
|
21.
|
QUARTERLY RESULTS (UNAUDITED)
|
|
Fiscal 2010
|
First
Quarter
|
Second
Quarter
|
Third
Quarter
|
Fourth
Quarter
|
Total
|
|||||||||||||||
|
Net sales
|
$ | 192,949 | $ | 226,661 | $ | 250,099 | $ | 278,020 | $ | 947,729 | ||||||||||
|
Gross profit
|
96,435 | 123,340 | 145,996 | 168,471 | 534,242 | |||||||||||||||
|
Operating income
|
31,178 | 52,726 | 72,568 | 88,487 | 244,959 | |||||||||||||||
|
Net income
|
27,368 | 44,485 | 69,403 | 75,749 | 217,005 | |||||||||||||||
|
Diluted net income per common share
|
0.15 | 0.24 | 0.37 | 0.40 | 1.16 | |||||||||||||||
|
Fiscal 2009
(as adjusted)
|
First
Quarter
|
Second
Quarter
|
Third
Quarter
|
Fourth
Quarter
|
Total
|
|||||||||||||||
|
Net sales
|
$ | 268,172 | $ | 269,706 | $ | 192,166 | $ | 173,253 | $ | 903,297 | ||||||||||
|
Gross profit
|
163,597 | 164,153 | 104,787 | 83,967 | 516,504 | |||||||||||||||
|
Operating income
|
86,632 | 87,181 | 40,474 | 19,041 | 233,328 | |||||||||||||||
|
Net income
|
75,547 | 75,720 | 72,356 | 21,964 | 245,587 | |||||||||||||||
|
Diluted net income per common share
|
0.40 | 0.40 | 0.39 | 0.12 | 1.31 | |||||||||||||||
|
22.
|
SUPPLEMENTAL FINANCIAL INFORMATION
|
|
Balance at
Beginning
of Year
|
Charged to Costs
and Expenses
|
Deductions (1)
|
Balance at
End of Year
|
|||||||||||||
|
Allowance for doubtful accounts:
|
||||||||||||||||
|
2010
|
$ | 3,176 | $ | 90 | $ | (157 | ) | $ | 3,109 | |||||||
|
2009
|
3,152 | 132 | (108 | ) | 3,176 | |||||||||||
|
2008
|
3,544 | --- | (392 | ) | 3,152 | |||||||||||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|